Skip to main content
. Author manuscript; available in PMC: 2016 Jul 11.
Published in final edited form as: Liver Transpl. 2015 Jan;21(1):4–12. doi: 10.1002/lt.24021

Figure 1.

Figure 1

21-day spontaneous survival (unadjusted) percentage for 1232 ALF patients with Grade III/IV Hepatic Encephalopathy
  • All patients: Controls= 1135, Therapeutic Hypothermia (TH) =97 (p= 0.24)
  • Acetaminophen (APAP) patients: Controls = 537, TH=61 (p= 0.78)
  • Non-acetaminophen (non-APAP) patients: Controls= 598, TH=36 (p= 0.90)